In this episode of the AMI investment perspective, the team discusses key economic and sector-specific updates. They explore a slight improvement in consumer confidence and a rare drop in the housing price index. In healthcare, the team highlights underwhelming lung cancer trial results from a therapeutics company and anticipates new information from an upcoming cancer conference. The team also examines strong AI-driven earnings in the tech sector, U.S. export restrictions on semiconductor technology, and AI’s potential to disrupt entry-level jobs. Finally, they note resilient consumer spending despite tariff concerns, with strong performances from retailers and a notable acquisition in the beauty industry.